Mitsubishi UFJ Asset Management
SCPH

Mitsubishi UFJ Asset Management’s scPharmaceuticals SCPH Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-23,053
Closed -$60.6K – 1641
2025
Q1 		$60.6K Sell
23,053
-418
-2% -$1.36K ﹤0.01% 1041
2024
Q4 		$84.3K Buy
23,471
+5,633
+32% +$21.6K ﹤0.01% 1049
2024
Q3 		$81.3K Sell
17,838
-650
-4% -$3.14K ﹤0.01% 1036
2024
Q2 		$80.4K Sell
18,488
-2,146
-10% -$9.43K ﹤0.01% 1026
2024
Q1 		$104K Sell
20,634
-5,568
-21% -$31.2K ﹤0.01% 1017
2023
Q4 		$166K Sell
26,202
-20,134
-43% -$115K ﹤0.01% 1036
2023
Q3 		$330K Sell
46,336
-1,047
-2% -$8.25K ﹤0.01% 973
2023
Q2 		$483K Buy
+47,383
New +$495K ﹤0.01% 921

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Mitsubishi UFJ Asset Management's SCPH Position: Q2 2025 in Review

Mitsubishi UFJ Asset Management sold out of scPharmaceuticals (SCPH) in Q2 2025, closing a stake of 23,053 shares — an estimated $60.6K sold.

Mitsubishi UFJ Asset Management first reported a position in SCPH in Q2 2023 and held it in 8 quarters. The position peaked at $483K in Q2 2023. 97 funds tracked by Wall St. Rank hold SCPH as of Q2 2025.

  • Mitsubishi UFJ Asset Management reported no remaining scPharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 23,053 scPharmaceuticals shares in Q2 2025, an estimated $60.6K.
  • Mitsubishi UFJ Asset Management first reported a position in scPharmaceuticals in Q2 2023 and held it in 8 quarters.
  • Mitsubishi UFJ Asset Management's scPharmaceuticals position peaked at $483K in Q2 2023.
  • 97 funds tracked by Wall St. Rank held scPharmaceuticals as of Q2 2025.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.